BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
POT
Potash Corp Of Saskatchewan
POT
|
+$716M |
| 2 |
Apple
AAPL
|
+$677M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$561M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$554M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$497M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.85B |
| 2 |
Equinix
EQIX
|
+$2.31B |
| 3 |
Tesla
TSLA
|
+$2.3B |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$1.87B |
| 5 |
TRLA
TRULIA INC (DEL)
TRLA
|
+$1.64B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.77% |
| 2 | Financials | 3.07% |
| 3 | Industrials | 1.75% |
| 4 | Healthcare | 1.67% |
| 5 | Materials | 1.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
GATX Corp
GATX
$6.33B
| $496K | ﹤0.01% |
7,411
-1,616
| -18% | -$106K |
|
|
BSL
1427
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$170M
| $495K | ﹤0.01% |
+27,619
| New | +$501K |
|
|
CBD
1428
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $491K | ﹤0.01% |
10,601
+1,507
| +17% | +$70.7K |
|
|
IIF
1429
Morgan Stanley India Investment Fund
IIF
$219M
| $491K | ﹤0.01% |
21,196
-22,017
| -51% | -$469K |
|
|
PNY
1430
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $490K | ﹤0.01% |
13,090
+2,416
| +23% | +$86.4K |
|
|
B
1431
PUT
Barrick Mining
B
$67.3B
| $489K | ﹤0.01% |
2,200
-90,954
| -98% | -$1.58M |
|
1432
PUT
Boeing
BA
$182B
| $486K | ﹤0.01% |
953
+75
| +9% | +$9.79K |
|
|
SC
1433
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $485K | ﹤0.01% |
24,971
+17,675
| +242% | +$377K |
|
|
GG
1434
PUT
DELISTED
Goldcorp Inc
GG
| $484K | ﹤0.01% |
14,667
+12,767
| +672% | +$317K |
|
1435
CALL
Newmont
NEM
$120B
| $482K | ﹤0.01% |
8,534
+4,884
| +134% | +$118K |
|
|
BHI
1436
CALL
DELISTED
Baker Hughes
BHI
| $481K | ﹤0.01% |
1,074
+774
| +258% | +$53.9K |
|
1437
PUT
ConocoPhillips
COP
$150B
| $481K | ﹤0.01% |
5,494
+3,821
| +228% | +$298K |
|
|
1438
CALL
Gilead Sciences
GILD
$171B
| $480K | ﹤0.01% |
1,251
+815
| +187% | +$63.4K |
|
1439
PUT
Goldman Sachs
GS
$304B
| $478K | ﹤0.01% |
3,214
+1,577
| +96% | +$254K |
|
1440
Viavi Solutions
VIAV
$10.6B
| $478K | ﹤0.01% |
67,352
+24,557
| +57% | +$167K |
|
1441
ResMed
RMD
$32.9B
| $477K | ﹤0.01% |
9,431
-14,960
| -61% | -$741K |
|
|
MTCN
1442
DELISTED
ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX)
MTCN
| $471K | ﹤0.01% |
+20,800
| New | +$491K |
|
1443
PUT
Ralph Lauren
RL
$23.1B
| $470K | ﹤0.01% |
2,407
+1,848
| +331% | +$285K |
|
1444
UDR
UDR
$12.2B
| $470K | ﹤0.01% |
16,428
-49,086
| -75% | -$1.32M |
|
1445
California Water Service
CWT
$3.1B
| $470K | ﹤0.01% |
19,424
+8,523
| +78% | +$192K |
|
|
RAX
1446
DELISTED
Rackspace Hosting Inc
RAX
| $469K | ﹤0.01% |
13,945
-12,619
| -48% | -$419K |
|
1447
Protalix BioTherapeutics
PLX
$190M
| $466K | ﹤0.01% |
12,770
-4,075
| -24% | -$164K |
|
1448
NCR Voyix
VYX
$1.17B
| $461K | ﹤0.01% |
21,394
-14,003
| -40% | -$283K |
|
|
CBL
1449
DELISTED
CBL& Associates Properties, Inc.
CBL
| $460K | ﹤0.01% |
24,185
-12,061
| -33% | -$223K |
|
|
SABA
1450
Saba Capital Income & Opportunities Fund II
SABA
$221M
| $458K | ﹤0.01% |
27,700
+9,350
| +51% | +$149K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2014 Portfolio in Review
As of Q2 2014, BNP Paribas Financial Markets held 4,108 positions worth $106B, down 17% from $129B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets deployed $44.2B of net new capital in Q2 2014, opening 765 new positions and adding to 1,315 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
By sector, the portfolio is most concentrated in Technology at 4.8% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $3.85B trimmed.
- BNP Paribas Financial Markets's largest Q2 2014 buy was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
- BNP Paribas Financial Markets added most to Potash Corp Of Saskatchewan in Q2 2014, an estimated $716M increase.
- BNP Paribas Financial Markets's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $3.85B.
- BNP Paribas Financial Markets fully exited Walter Investment Mgt Corp in Q2 2014, selling an estimated $477M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $106B portfolio in Q2 2014.
- BNP Paribas Financial Markets opened 765 new positions and closed 285 in Q2 2014.
- BNP Paribas Financial Markets's portfolio value fell 17% quarter-over-quarter to $106B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2014, filed 14 Aug 2014.